| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Current Ratio | 151 | % | -17.5% |
| Debt-to-equity | 465 | % | +215% |
| Return On Equity | -3.17K | % | -141% |
| Return On Assets | -560 | % | -5.52% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Entity Common Stock, Shares Outstanding | 10.9M | shares | |
| Common Stock, Shares, Outstanding | 7.78M | shares | -49.4% |
| Weighted Average Number of Shares Outstanding, Basic | 7.66M | shares | +789% |
| Weighted Average Number of Shares Outstanding, Diluted | 7.66M | shares | +789% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Research and Development Expense | 5.01M | USD | +264% |
| General and Administrative Expense | 10.4M | USD | -23.8% |
| Operating Income (Loss) | -15.4M | USD | -2.47% |
| Nonoperating Income (Expense) | -2.35M | USD | +70.1% |
| Net Income (Loss) Attributable to Parent | -17.7M | USD | +26.4% |
| Earnings Per Share, Basic | -3 | USD/shares | +93% |
| Earnings Per Share, Diluted | -3 | USD/shares | +92.9% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Accounts Receivable, after Allowance for Credit Loss, Current | 500K | USD | |
| Assets, Current | 800K | USD | -84.5% |
| Assets | 800K | USD | -84.5% |
| Accounts Payable, Current | 2.04M | USD | |
| Employee-related Liabilities, Current | 873K | USD | +71.1% |
| Accrued Liabilities, Current | 965K | USD | -5.3% |
| Liabilities, Current | 2.11M | USD | -13.1% |
| Liabilities | 2.61M | USD | -9.44% |
| Retained Earnings (Accumulated Deficit) | -58.7M | USD | -43% |
| Stockholders' Equity Attributable to Parent | -1.81M | USD | -180% |
| Liabilities and Equity | 800K | USD | -84.5% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Net Cash Provided by (Used in) Operating Activities | -3.07M | USD | -2.85% |
| Net Cash Provided by (Used in) Financing Activities | -15.3K | USD | -100% |
| Common Stock, Shares Authorized | 200M | shares | 0% |
| Common Stock, Shares, Issued | 7.78M | shares | -49.4% |
| Common Stock, Par or Stated Value Per Share | 0 | USD/shares | 0% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | 324K | USD | -89.4% |
| Deferred Tax Assets, Valuation Allowance | 7.21M | USD | +49.2% |
| Deferred Tax Assets, Gross | 7.21M | USD | +49.2% |
| Deferred Tax Assets, Operating Loss Carryforwards | 5.41M | USD | +46.8% |
| Preferred Stock, Shares Authorized | 10M | shares | 0% |
| Additional Paid in Capital | 56.9M | USD | +31.4% |
| Deferred Tax Assets, Net of Valuation Allowance | 0 | USD | |
| Share-based Payment Arrangement, Expense | 1.51M | USD | -30.3% |
| Interest Expense | 9.17K | USD | |
| Preferred Stock, Par or Stated Value Per Share | 0 | USD/shares | 0% |